BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11721369)

  • 21. Relationship between degradation of PML-RARalpha and differentiation.
    Naoe T; Kitamura K
    Blood; 1999 Aug; 94(4):1478-9. PubMed ID: 10484633
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of retinoic acid isomers on proliferation, differentiation and PML relocalization in the APL cell line NB4.
    Zhu J; Shi XG; Chu HY; Tong JH; Wang ZY; Naoe T; Waxman S; Chen SJ; Chen Z
    Leukemia; 1995 Feb; 9(2):302-9. PubMed ID: 7869768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
    Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
    Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiation.
    Mainardi S; Pelosi A; Palescandolo E; Riccioni R; Fontemaggi G; Diverio D; Testa U; Sacchi A; Grignani F; Lo-Coco F; Levrero M; Blandino G; Rizzo MG
    Cell Death Differ; 2007 Nov; 14(11):1968-71. PubMed ID: 17690711
    [No Abstract]   [Full Text] [Related]  

  • 25. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
    Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
    Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
    Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphologic heterogeneity of acute promyelocytic leukemia: therapy-related acute promyelocytic leukemia presenting with FAB-M2 morphology.
    Sinha S; Aish L; Oo TH
    Am J Hematol; 2006 Jun; 81(6):475-6. PubMed ID: 16680741
    [No Abstract]   [Full Text] [Related]  

  • 28. The t(15;17) translocation in acute promyelocytic leukemia.
    Lavau C; Jansen J; Dejean A
    Pathol Biol (Paris); 1995 Mar; 43(3):188-96. PubMed ID: 7675545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the acute promyelocytic leukemia PML/RAR alpha protein on differentiation and survival of myeloid precursors.
    Fagioli M; Grignani F; Ferrucci PF; Alcalay M; Mencarelli A; Nicoletti I; Grignani F; Pelicci PG
    Leukemia; 1994 Apr; 8 Suppl 1():S7-11. PubMed ID: 8152308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
    Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
    Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous detection of type A and type B PML/retinoic acid receptor alpha fusion transcripts in acute promyelocytic leukemia.
    Kohli V; Koller CA
    Blood; 1995 Feb; 85(3):854-5. PubMed ID: 7833490
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of the histone deacetylase complex in acute promyelocytic leukaemia.
    Lin RJ; Nagy L; Inoue S; Shao W; Miller WH; Evans RM
    Nature; 1998 Feb; 391(6669):811-4. PubMed ID: 9486654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.
    Perego RA; Marenco P; Bianchi C; Cairoli R; Urbano M; Nosari AM; Muti G; Morra E; Del Monte U
    Leukemia; 1996 Feb; 10(2):207-12. PubMed ID: 8637228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukemia: the sophisticated subversion of hematopoiesis by nuclear receptor oncoproteins.
    Stunnenberg HG; Garcia-Jimenez C; Betz JL
    Biochim Biophys Acta; 1999 Jan; 1423(1):F15-33. PubMed ID: 9989207
    [No Abstract]   [Full Text] [Related]  

  • 35. Life, death and nuclear spots.
    Hess JL; Korsmeyer SJ
    Nat Genet; 1998 Nov; 20(3):220-2. PubMed ID: 9806533
    [No Abstract]   [Full Text] [Related]  

  • 36. Deregulated TGF-beta signaling in leukemogenesis.
    Lin HK; Bergmann S; Pandolfi PP
    Oncogene; 2005 Aug; 24(37):5693-700. PubMed ID: 16123802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promyelocytic leukemia with basophil-like granules.
    Piva E; Tosato F
    Blood; 2020 Jul; 136(3):372. PubMed ID: 32673393
    [No Abstract]   [Full Text] [Related]  

  • 38. Ear involvement in acute promyelocytic leukemia.
    Helbig G; Koclęga A; Liwoch R; Wiśniewski-Piąty K; Bober G
    Pol Arch Intern Med; 2017 Jun; 127(6):448-449. PubMed ID: 28680029
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of the progesterone receptor functions.
    Savouret JF; Muchardt C; Quesne M; Mantel A; De The H; Milgrom E
    Ann N Y Acad Sci; 1998 May; 839():138-42. PubMed ID: 9629139
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute promyelocytic leukaemia with myeloperoxidase-negative rectangular inclusions.
    Mo X; Chen H
    Br J Haematol; 2020 Jan; 188(1):8. PubMed ID: 31821543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.